244 related articles for article (PubMed ID: 29987602)
1. Preoperative Therapy for Gastric Adenocarcinoma is Protective for Poor Oncologic Outcomes in Patients with Complications After Gastrectomy.
Vicente D; Ikoma N; Chiang YJ; Fournier K; Tzeng CD; Song S; Mansfield P; Ajani J; Badgwell BD
Ann Surg Oncol; 2018 Sep; 25(9):2720-2730. PubMed ID: 29987602
[TBL] [Abstract][Full Text] [Related]
2. Interaction of Postoperative Morbidity and Receipt of Adjuvant Therapy on Long-Term Survival After Resection for Gastric Adenocarcinoma: Results From the U.S. Gastric Cancer Collaborative.
Jin LX; Sanford DE; Squires MH; Moses LE; Yan Y; Poultsides GA; Votanopoulos KI; Weber SM; Bloomston M; Pawlik TM; Hawkins WG; Linehan DC; Schmidt C; Worhunsky DJ; Acher AW; Cardona K; Cho CS; Kooby DA; Levine EA; Winslow E; Saunders N; Spolverato G; Colditz GA; Maithel SK; Fields RC
Ann Surg Oncol; 2016 Aug; 23(8):2398-408. PubMed ID: 27006126
[TBL] [Abstract][Full Text] [Related]
3. Preoperative therapy and long-term survival in gastric cancer: One size does not fit all.
Biondi A; Agnes A; Del Coco F; Pozzo C; Strippoli A; D'Ugo D; Persiani R
Surg Oncol; 2018 Sep; 27(3):575-583. PubMed ID: 30217321
[TBL] [Abstract][Full Text] [Related]
4. Postoperative Morbidity and Mortality Rates are Not Increased for Patients with Gastric and Gastroesophageal Cancer Who Undergo Preoperative Chemoradiation Therapy.
Badgwell B; Ajani J; Blum M; Ho L; Fournier K; Chiang YJ; Matamoros A; Das P; Mansfield P
Ann Surg Oncol; 2016 Jan; 23(1):156-62. PubMed ID: 26059652
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant Therapy Improves Survival for T2N0 Gastric Cancer Patients with Sub-optimal Lymphadenectomy.
In H; Kantor O; Sharpe SM; Baker MS; Talamonti MS; Posner MC
Ann Surg Oncol; 2016 Jun; 23(6):1956-62. PubMed ID: 26753752
[TBL] [Abstract][Full Text] [Related]
6. Impact of Postoperative Complication and Completion of Multimodality Therapy on Survival in Patients Undergoing Gastrectomy for Advanced Gastric Cancer.
Li SS; Udelsman BV; Parikh A; Klempner SJ; Clark JW; Roeland EJ; Wo JY; Hong TS; Mullen JT
J Am Coll Surg; 2020 Jun; 230(6):912-924. PubMed ID: 32035978
[TBL] [Abstract][Full Text] [Related]
7. Association Between Waiting Time from Diagnosis to Treatment and Survival in Patients with Curable Gastric Cancer: A Population-Based Study in the Netherlands.
Brenkman HJF; Visser E; van Rossum PSN; Siesling S; van Hillegersberg R; Ruurda JP
Ann Surg Oncol; 2017 Jul; 24(7):1761-1769. PubMed ID: 28353020
[TBL] [Abstract][Full Text] [Related]
8. Surgical complications in gastric cancer patients preoperatively treated with chemotherapy: their risk factors and clinical relevance.
An JY; Kim KM; Kim YM; Cheong JH; Hyung WJ; Noh SH
Ann Surg Oncol; 2012 Aug; 19(8):2452-8. PubMed ID: 22395984
[TBL] [Abstract][Full Text] [Related]
9. Predictors of Survival in Patients with Resectable Gastric Cancer Treated with Preoperative Chemoradiation Therapy and Gastrectomy.
Badgwell B; Blum M; Estrella J; Chiang YJ; Das P; Matamoros A; Fournier K; Mansfield P; Ajani J
J Am Coll Surg; 2015 Jul; 221(1):83-90. PubMed ID: 26002780
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ?
Kneuertz PJ; Hofstetter WL; Chiang YJ; Das P; Blum M; Elimova E; Mansfield P; Ajani J; Badgwell B
Ann Surg Oncol; 2016 Feb; 23(2):626-32. PubMed ID: 26564243
[TBL] [Abstract][Full Text] [Related]
11. Effects of Preoperative Malnutrition on Short- and Long-Term Outcomes of Patients with Gastric Cancer: Can We Do Better?
Zheng HL; Lu J; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu R; Huang CM; Zheng CH
Ann Surg Oncol; 2017 Oct; 24(11):3376-3385. PubMed ID: 28699132
[TBL] [Abstract][Full Text] [Related]
12. Impact of minimally invasive gastrectomy on use of and time to adjuvant chemotherapy for gastric adenocarcinoma.
Farrow NE; Freischlag KW; Adam MA; Blazer DG
J Surg Oncol; 2020 Mar; 121(3):486-493. PubMed ID: 31919862
[TBL] [Abstract][Full Text] [Related]
13. Short- and Long-Term Outcomes of Patients Requiring Gastrectomy During Cytoreductive Surgery and Intraperitoneal Chemotherapy for Lower-Gastrointestinal Malignancies: A Propensity Score-Matched Analysis.
Singh B; Fisher OM; Singh G; Lansom J; Bock M; Kozman M; Alzahrani N; Liauw W; Morris DL
Ann Surg Oncol; 2019 Oct; 26(11):3627-3635. PubMed ID: 31292804
[TBL] [Abstract][Full Text] [Related]
14. Surgical and long-term oncologic outcomes of laparoscopic and open gastrectomy for serosa-positive (pT4a) gastric cancer: A propensity score-matched analysis.
Li Z; Liu Y; Hao Y; Bai B; Yu D; Zhao Q
Surg Oncol; 2019 Mar; 28():167-173. PubMed ID: 30851895
[TBL] [Abstract][Full Text] [Related]
15. Posttherapy nodal status, not graded histologic response, predicts survival after neoadjuvant chemotherapy for advanced gastric cancer.
Fujitani K; Mano M; Hirao M; Kodama Y; Tsujinaka T
Ann Surg Oncol; 2012 Jun; 19(6):1936-43. PubMed ID: 22187120
[TBL] [Abstract][Full Text] [Related]
16. Relationship between Clavien-Dindo classification and long-term survival outcomes after curative resection for gastric cancer: A propensity score-matched analysis.
Li Z; Bai B; Ji G; Li J; Zhao Q
Int J Surg; 2018 Dec; 60():67-73. PubMed ID: 30399450
[TBL] [Abstract][Full Text] [Related]
17. Co-morbidities Rather than Age Impact Outcomes in Patients Receiving Preoperative Therapy for Gastroesophageal Adenocarcinoma.
Charalampakis N; Xiao L; Lin Q; Elimova E; Shimodaira Y; Harada K; Rogers JE; Mares J; Amlashi FG; Minsky BD; Das P; Hofstetter WL; Matamoros A; Sagebiel TL; Blum-Murphy MA; Lee JH; Weston B; Bhutani MS; Mansfield PF; Estrella JS; Badgwell BD; Ajani JA
Ann Surg Oncol; 2017 Aug; 24(8):2291-2301. PubMed ID: 27770339
[TBL] [Abstract][Full Text] [Related]
18. Chemoresponse after non-curative gastrectomy for M1 gastric cancer.
Shin HB; Lee SH; Son YG; Ryu SW; Sohn SS
World J Surg Oncol; 2015 Jan; 13():13. PubMed ID: 25634223
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy is an additional option for locally advanced gastric cancer after radical gastrectomy with D2 lymphadenectomy: a retrospective control study.
Chen L; Zhang C; Yao Z; Cui M; Xing J; Yang H; Zhang N; Liu M; Xu K; Tan F; Li Y; Jiang B; Su X
BMC Cancer; 2021 Aug; 21(1):974. PubMed ID: 34461860
[TBL] [Abstract][Full Text] [Related]
20. Impact of ypT, ypN, and Adjuvant Therapy on Survival in Gastric Cancer Patients Treated with Perioperative Chemotherapy and Radical Surgery.
Coimbra FJF; de Jesus VHF; Ribeiro HSC; Diniz AL; de Godoy AL; de Farias IC; Felismino T; Mello CAL; Almeida MF; Begnami MDFS; Dias-Neto E; Riechelmann RSP; da Costa WL
Ann Surg Oncol; 2019 Oct; 26(11):3618-3626. PubMed ID: 31222685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
